These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2577460)
1. Diuretic agents versus beta-blockers. Comparison of effects on mortality, stroke, and coronary events. Furberg CD; Cutler JA Hypertension; 1989 May; 13(5 Suppl):I57-61. PubMed ID: 2577460 [TBL] [Abstract][Full Text] [Related]
2. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. Wilhelmsen L; Berglund G; Elmfeldt D; Fitzsimons T; Holzgreve H; Hosie J; Hörnkvist PE; Pennert K; Tuomilehto J; Wedel H J Hypertens; 1987 Oct; 5(5):561-72. PubMed ID: 2892881 [TBL] [Abstract][Full Text] [Related]
3. Diuretic agents and beta-blockers in the treatment of hypertension. Dollery C Hypertension; 1989 May; 13(5 Suppl):I62-5. PubMed ID: 2577461 [TBL] [Abstract][Full Text] [Related]
4. Association between cardiovascular outcomes and antihypertensive drug treatment in older women. Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916 [TBL] [Abstract][Full Text] [Related]
5. Beta-blockers and diuretics. The HAPPHY and MAPHY studies. Berglund G Clin Exp Hypertens A; 1989; 11(5-6):1137-48. PubMed ID: 2571434 [TBL] [Abstract][Full Text] [Related]
6. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. Black HR; Elliott WJ; Grandits G; Grambsch P; Lucente T; White WB; Neaton JD; Grimm RH; Hansson L; Lacourciere Y; Muller J; Sleight P; Weber MA; Williams G; Wittes J; Zanchetti A; Anders RJ; JAMA; 2003 Apr 23-30; 289(16):2073-82. PubMed ID: 12709465 [TBL] [Abstract][Full Text] [Related]
7. Beta-blockade in the primary prevention of coronary heart disease in hypertensive patients. Review of present evidence. Wikstrand J; Berglund G; Tuomilehto J Circulation; 1991 Dec; 84(6 Suppl):VI93-100. PubMed ID: 1683615 [TBL] [Abstract][Full Text] [Related]
8. Medical Research Council trial of treatment of hypertension in older adults: principal results. MRC Working Party. BMJ; 1992 Feb; 304(6824):405-12. PubMed ID: 1445513 [TBL] [Abstract][Full Text] [Related]
9. Review of the long-term controlled trials of usefulness of therapy for systemic hypertension. Gifford RW Am J Cardiol; 1989 Jan; 63(4):8B-16B. PubMed ID: 2563189 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive therapy and the concept of total cardiovascular protection. Mason DT; Chan MC; Lee G Am J Cardiol; 1987 Sep; 60(9):29E-32E. PubMed ID: 2889351 [TBL] [Abstract][Full Text] [Related]
11. Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study. Hansson L; Hedner T; Lund-Johansen P; Kjeldsen SE; Lindholm LH; Syvertsen JO; Lanke J; de Faire U; Dahlöf B; Karlberg BE Lancet; 2000 Jul; 356(9227):359-65. PubMed ID: 10972367 [TBL] [Abstract][Full Text] [Related]
12. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Dahlöf B; Sever PS; Poulter NR; Wedel H; Beevers DG; Caulfield M; Collins R; Kjeldsen SE; Kristinsson A; McInnes GT; Mehlsen J; Nieminen M; O'Brien E; Ostergren J; Lancet; 2005 Sep 10-16; 366(9489):895-906. PubMed ID: 16154016 [TBL] [Abstract][Full Text] [Related]
13. A meta-analysis of mortality and coronary prevention in hypertensive patients treated with beta-receptor blockers. Shinton RA; Beevers DG J Hum Hypertens; 1990 Jun; 4 Suppl 2():31-4. PubMed ID: 1973461 [TBL] [Abstract][Full Text] [Related]
14. Hyperlipidemia of diuretic therapy. Ames R Arch Mal Coeur Vaiss; 1998 Sep; 91 Suppl():23-7. PubMed ID: 9805566 [TBL] [Abstract][Full Text] [Related]
15. Treating essential hypertension. The first choice is usually a thiazide diuretic. Prescrire Int; 2014 Sep; 23(152):215-20. PubMed ID: 25325125 [TBL] [Abstract][Full Text] [Related]
16. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
17. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847 [TBL] [Abstract][Full Text] [Related]
18. The Role of Beta-Blockers in the Treatment of Hypertension. Cruickshank JM Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711 [TBL] [Abstract][Full Text] [Related]
19. [Cooperative study of systolic arterial hypertension in the elderly patient (SHEP). Comments]. Ménard J; Chatellier G Presse Med; 1992 Nov; 21(37):1762-7. PubMed ID: 1362612 [TBL] [Abstract][Full Text] [Related]
20. Experiences from hypertension trials--effects on stroke and coronary heart disease. Berglund G Drugs; 1988; 36 Suppl 3():5-8. PubMed ID: 3076121 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]